• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于靶向MRI引导下前列腺穿刺活检的多参数3-T MRI标准化评分]

[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].

作者信息

Arsov C, Blondin D, Rabenalt R, Antoch G, Albers P, Quentin M

机构信息

Klinik für Urologie, Universitätsklinikum Düsseldorf, Düsseldorf.

出版信息

Urologe A. 2012 Jun;51(6):848-56. doi: 10.1007/s00120-012-2825-6.

DOI:10.1007/s00120-012-2825-6
PMID:22476739
Abstract

BACKGROUND

The use of multi-parametric MRI and MRI-guided biopsy for the detection of prostate cancer is rapidly increasing. This is a pilot study to evaluate the consensus-based international MRI scoring system as decision criterion for targeted MRI-guided prostate biopsy.

MATERIAL AND METHODS

After a multi-parametric 3-T MRI (T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast-enhanced MRI) in 23 consecutive patients a total of 47 lesions were scored according to a 5-point scale for each MRI sequence. A total score of ≥ 10 points was considered to be suspicious for prostate cancer. All 47 lesions were histologically assessed after MRI-guided biopsy.

RESULTS

At the cut-off score of 10 points, sensitivity, specificity, negative predictive value and positive predictive value of multi-parametric MRI were 94.1, 43.3, 92.9 and 48.5%, respectively.

CONCLUSIONS

A standardised scoring of lesions on multi-parametric MRI is feasible. The cut-off value leads to excellent values for sensitivity and negative predictive value. The values for specificity and positive predictive value are modest. Lesions with a total score <10 points are very unlikely to be malignant.

摘要

背景

多参数磁共振成像(MRI)和MRI引导下活检在前列腺癌检测中的应用正在迅速增加。这是一项初步研究,旨在评估基于共识的国际MRI评分系统作为MRI引导下靶向前列腺活检的决策标准。

材料与方法

对23例连续患者进行多参数3-T MRI(T2加权成像、扩散加权成像和动态对比增强MRI)检查后,根据每个MRI序列的5分制对总共47个病灶进行评分。总分≥10分被认为可疑为前列腺癌。在MRI引导下活检后,对所有47个病灶进行组织学评估。

结果

在截断分数为10分时,多参数MRI的敏感性、特异性、阴性预测值和阳性预测值分别为94.1%、43.3%、92.9%和48.5%。

结论

对多参数MRI上的病灶进行标准化评分是可行的。截断值导致敏感性和阴性预测值的良好结果。特异性和阳性预测值的结果一般。总分<10分的病灶极不可能是恶性的。

相似文献

1
[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].[用于靶向MRI引导下前列腺穿刺活检的多参数3-T MRI标准化评分]
Urologe A. 2012 Jun;51(6):848-56. doi: 10.1007/s00120-012-2825-6.
2
3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization.基于评分系统对目标病变特征进行表征的3-T 孔内磁共振引导前列腺活检。
Acta Radiol. 2013 Dec;54(10):1224-9. doi: 10.1177/0284185113492972. Epub 2013 Jul 22.
3
Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.前列腺影像报告和数据系统在前列腺靶向活检检测前列腺癌中的应用评价。
Invest Radiol. 2014 Jun;49(6):411-20. doi: 10.1097/RLI.0000000000000030.
4
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
5
[Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].[实时磁共振成像/超声融合引导活检提高了先前活检患者前列腺癌的检出率]
Aktuelle Urol. 2014 May;45(3):197-203. doi: 10.1055/s-0034-1375682. Epub 2014 Jun 5.
6
Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.计算机断层扫描下的前列腺癌:与多参数磁共振成像及组织病理学的直接比较
Eur J Radiol. 2016 Jan;85(1):261-267. doi: 10.1016/j.ejrad.2015.10.013. Epub 2015 Oct 24.
7
Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?动态磁共振成像及计算机辅助检测与胆碱磁共振波谱分析在前列腺癌病变特征检测水平方面的比较:孰优孰劣?
Int J Radiat Biol. 2009 Sep;85(9):814-24. doi: 10.1080/09553000903090027.
8
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.弥散加权和动态对比增强 MRI 在放射治疗后局部复发性前列腺癌检测中的增量价值:初步结果。
Eur Radiol. 2011 Sep;21(9):1970-8. doi: 10.1007/s00330-011-2130-6. Epub 2011 May 1.
9
Role of multi-parametric (mp) MRI in prostate cancer.多参数磁共振成像(mpMRI)在前列腺癌中的作用。
J Pak Med Assoc. 2018 Jan;68(1):98-104.
10
Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.前列腺多参数磁共振成像:两种评分系统的诊断性能及阅片者间一致性
Br J Radiol. 2016 Jun;89(1062):20151056. doi: 10.1259/bjr.20151056. Epub 2016 Mar 23.

引用本文的文献

1
Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial.一项前瞻性随机试验中,磁共振引导下的孔内活检与磁共振成像/超声融合引导下的前列腺活检患者舒适度的比较。
World J Urol. 2016 Feb;34(2):215-20. doi: 10.1007/s00345-015-1612-6. Epub 2015 Jun 9.
2
Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy.高 b 值扩散加权图像上前列腺病变信号强度增高是恶性病变的预测征象。
Eur Radiol. 2014 Jan;24(1):209-13. doi: 10.1007/s00330-013-2999-3. Epub 2013 Aug 31.
3
Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

本文引用的文献

1
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.一种新型立体定向前列腺活检系统,整合了术前磁共振成像和实时超声融合技术。
J Urol. 2011 Dec;186(6):2214-20. doi: 10.1016/j.juro.2011.07.102. Epub 2011 Oct 19.
2
Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.前列腺 MRI:1.5T 弥散加权成像与前列腺切除术格里森评分相关性优于经直肠超声引导下活检在周边带肿瘤。
Eur Radiol. 2012 Feb;22(2):468-75. doi: 10.1007/s00330-011-2269-1. Epub 2011 Sep 14.
3
以腔内MRI引导活检为参考标准时,前列腺MRI的欧洲泌尿生殖放射学会(ESUR)评分的阅片者间一致性。
Eur Radiol. 2013 Nov;23(11):3185-90. doi: 10.1007/s00330-013-2922-y. Epub 2013 Jun 12.
Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
3T 直肠内磁共振弥散加权成像在前列腺癌中的应用:肿瘤检测及侵袭性评估。
Radiology. 2011 Jun;259(3):775-84. doi: 10.1148/radiol.11102066. Epub 2011 Mar 24.
4
Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.可疑前列腺癌区域:至少进行过一次经直肠超声引导下前列腺活检且结果为阴性的患者——多参数磁共振成像用于检测和活检规划。
Radiology. 2011 Apr;259(1):162-72. doi: 10.1148/radiol.10101251. Epub 2011 Jan 13.
5
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.磁共振成像在前列腺癌的检测、定位和特征描述中的应用:来自欧洲共识会议的建议。
Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21.
6
Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?表观扩散系数(ADC)值在前列腺癌患者中的临床应用:ADC 值能否有助于评估前列腺癌的侵袭性?
J Magn Reson Imaging. 2011 Jan;33(1):167-72. doi: 10.1002/jmri.22317.
7
Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.磁共振成像引导下前列腺活检在重复阴性前列腺活检和前列腺特异性抗原升高的男性中的应用。
J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14.
8
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients.联合磁共振成像和波谱分析评估 PSA 升高的高级别前列腺癌:356 例患者的单机构经验。
Eur J Radiol. 2011 Feb;77(2):340-5. doi: 10.1016/j.ejrad.2009.08.007. Epub 2009 Sep 8.
9
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
10
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.在多模态3T磁共振成像上识别出的前列腺肿瘤可疑区域的32通道线圈3T磁共振引导活检:技术与可行性
Invest Radiol. 2008 Oct;43(10):686-94. doi: 10.1097/RLI.0b013e31817d0506.